Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38319835.
- Also identified by DOI 10.1056/EVIDctcs2200149.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Outpatient Trials in the Covid-19 Era and BeyondA group of investigators had a meeting at the National Heart, Lung, and Blood Institute in May 2020 to discuss ways to decrease thrombotic complications among symptomatic outpatients with Covid-19. The investigators discuss their approach to three specific challenges: conducting a trial remotely, working through regulatory hurdles, and recruiting a diverse population of participants.
Medical subject headings
- COVID-19